Philips CEO Sees Doubling of Sales Growth Rate as Unlikely -- Market Talk

Dow Jones12-04

1012 GMT - While Philips expects organic sales growth to improve in 2026, doubling of the growth rate is unlikely, Chief Executive Roy Jakobs told Citi analysts at the Global Healthcare Conference. Philips saw growth improve 1% in 2024 and guides for around 2% in 2025, Citi analysts say in a research note. The Dutch health-technology company's call of caution means that organic sales growth should be more than 2% but less than 4%, compared with company-compiled consensus of 4.5%, Citi says. Jakobs said the company still expects margins to expand in 2026, but tariff impacts will almost double year-on-year, Citi notes. Nevertheless, Citi sees Philips on track, the analysts say. Shares trade 7.4% lower at 22.27 euros. (nina.kienle@wsj.com)

 

(END) Dow Jones Newswires

December 04, 2025 05:16 ET (10:16 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment